Product Details

Oncept IL-2

• MA holder: Boehringer Ingelheim Vetmedica GmbH
• VM number: 61700/5065
• Previous VM Numbers: EU/2/13/150/001
• Territory: Great Britain
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Post Authorisation Assessment
• Authorised from: 03/05/2013
• Authorisation route: National
• Active substances:
  • Feline interleukin-2 recombinant canarypox virus
• Target species:
  • Cats
• Distribution category: POM-V
• Distributors:
  • Boehringer Ingelheim Vetmedica GmbH